Mineralocorticoid receptor antagonists reduce new-onset atrial fibrillation across the cardio-kidney-metabolic spectrum: a meta-analysis of randomized clinical trials
Authors
Francisco Vasques‐Nóvoa (ORCID: https://orcid.org/0000-0001-9701-8538)
Pedro Marques (ORCID: https://orcid.org/0000-0003-0473-4864)
Faiez Zannad
Institutions
Universidade do Porto (PT)
Princess Grace Hospital Centre (MC)
Hospital de São João (PT)
French Clinical Research Infrastructure Network (FR)
Mineralocorticoid receptor antagonists reduce new-onset atrial fibrillation across the cardio-kidney-metabolic spectrum: a meta-analysis of randomized clinical trials
Francisco Vasques‐Nóvoa, Pedro Marques, Faiez Zannad
Journal
European Journal of Heart Failure
Topics
Hormonal Regulation and Hypertension
article
Mineralocorticoid receptor antagonists reduce new-onset atrial fibrillation across the cardio-kidney-metabolic spectrum: a meta-analysis of randomized clinical trials
Francisco Vasques‐Nóvoa, Pedro Marques, Faiez Zannad
article en
Abstract
No abstract available for this paper.
Publication Tag
European Journal of Heart Failure
Institutions
Universidade do Porto (PT), Princess Grace Hospital Centre (MC), Hospital de São João (PT), French Clinical Research Infrastructure Network (FR)